VistaGen Therapeutics is Biotechnology in United States that focus on VistaGen Therapeutics Inc business. Founded in 1998. They cover business area such as VistaGen Therapeutics Inc, a biotechnology firm, its clinical stage, product candidate, patient, disease, disorder, Phase II development, an inadequate response, standard antidepressant, therapeutic potential, indication, anxiety, phobia, an odorless, fast-act synthetic neurosteroid, depression.
1998
( 26 years old in 2024 )
VistaGen Therapeutics Inc
-
343 Allerton Avenue
South San Francisco, CA 94080
United States
Private
VistaGen Therapeutics Inca biotechnology firmits clinical stageproduct candidatepatientdiseasedisorderPhase II developmentan inadequate responsestandard antidepressanttherapeutic potentialindicationanxietyphobiaan odorlessfast-act synthetic neurosteroiddepression
* We use standard office opening hours in near VistaGen Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
VistaGen Therapeutics is Biotechnology business from United States that founded in 1998 (26 years old in 2024), VistaGen Therapeutics business is focusing on VistaGen Therapeutics Inc.
VistaGen Therapeutics headquarter office and corporate office address is located in 343 Allerton Avenue South San Francisco, CA 94080 United States.
VistaGen Therapeutics was founded in United States.
In 2024, VistaGen Therapeutics is currently focus on VistaGen Therapeutics Inc sector.
Above is snippet of Google Trends for "VistaGen Therapeutics Inc" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with VistaGen Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
